US Stock MarketDetailed Quotes

AFIB Acutus Medical

Watchlist
  • 0.066
  • +0.003+4.45%
15min DelayClose Nov 22 16:00 ET
1.97MMarket Cap-45P/E (TTM)

Acutus Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-152.23%-2.76M
-8.20%-6.2M
-31.23%-6.95M
35.65%-19.85M
-134.21%-14.1M
124.72%5.28M
75.17%-5.73M
80.82%-5.3M
69.06%-30.85M
282.49%41.21M
Net income from continuing operations
40.72%-808K
91.45%-362K
51.99%-2.06M
-106.14%-81.66M
-575.15%-71.79M
93.33%-1.36M
-174.06%-4.24M
89.30%-4.28M
66.34%-39.62M
148.32%15.11M
Operating gains losses
40.48%-2.26M
-260.23%-3.43M
5.43%-2.51M
83.20%-12.02M
86.80%-4.61M
-306.75%-3.8M
---953K
---2.65M
-255,639.29%-71.55M
---34.93M
Depreciation and amortization
-21.41%257K
-18.21%256K
2.72%264K
-27.65%874K
99.46%-23K
-80.96%327K
-83.52%313K
-86.38%257K
-82.47%1.21M
-354.59%-4.3M
Other non cash items
48.67%168K
561.29%205K
-71.38%87K
6.20%70.44M
4.33%69.99M
352.00%113K
102.66%31K
-21.04%304K
41,553.13%66.33M
2,988.49%67.08M
Change In working capital
-102.39%-240K
-266.91%-2.99M
-386.73%-2.92M
135.04%916K
-457.99%-9.32M
379.62%10.03M
-123.54%-816K
119.96%1.02M
30.99%-2.61M
150.43%2.6M
-Change in receivables
-127.42%-1.18M
-177.28%-1.5M
-147.84%-819K
170.23%3.63M
22.66%-4.32M
795.79%4.29M
409.16%1.95M
161.37%1.71M
-250.78%-5.17M
-1,103.05%-5.59M
-Change in inventory
-92.16%1.02M
154.44%675K
-588.03%-1.61M
-3,721.54%-2.48M
-648.59%-14.05M
1,734.18%13.04M
-153.61%-1.24M
80.69%-234K
98.32%-65K
-0.48%-1.88M
-Change in prepaid assets
-94.48%104K
111.07%65K
-83.59%117K
-73.25%656K
-120.07%-1.35M
367.61%1.88M
-459.05%-587K
120.45%713K
116.42%2.45M
466.11%6.75M
-Change in payables and accrued expense
100.42%39K
-135.76%-2.04M
49.90%-487K
-133.50%-412K
145.53%10.65M
-211.83%-9.22M
-190.41%-867K
12.35%-972K
81.42%1.23M
589.67%4.34M
-Change in other current assets
----
----
--0
--0
----
----
----
--0
--0
-157.36%-386K
-Change in other current liabilities
-733.33%-228K
-179.10%-187K
42.08%-117K
55.55%-473K
62.15%-240K
119.78%36K
63.98%-67K
-225.81%-202K
-90.68%-1.06M
-340.28%-634K
Cash from discontinued investing activities
95.12%-942K
92.00%-771K
4.34%-9.98M
25.49%-43.27M
-3.92M
-19.29M
-9.64M
-10.43M
-58.07M
Operating cash flow
73.60%-3.7M
54.62%-6.98M
-7.64%-16.93M
29.01%-63.12M
-6.81%-18.01M
34.38%-14.01M
33.46%-15.37M
43.03%-15.73M
10.80%-88.92M
25.32%-16.86M
Investing cash flow
Cash flow from continuing investing activities
-82.57%2.95M
-70.68%4.44M
-42.13%8.95M
-44.92%59.77M
-23.47%12.22M
403.68%16.95M
-79.31%15.14M
-3.39%15.46M
469.10%108.51M
239.81%15.97M
Net PPE purchase and sale
98.78%-5K
94.95%-38K
-320.00%-105K
3.95%-219K
-56.88%968K
45.70%-410K
-19.37%-752K
97.70%-25K
97.71%-228K
166.30%2.25M
Net business purchase and sale
--2.96M
--2.98M
-57.06%7.3M
-75.71%17M
--0
--0
--0
--17M
--70M
--20M
Net investment purchase and sale
--0
-90.56%1.5M
215.21%1.75M
10.98%42.99M
279.44%11.26M
321.33%17.36M
-33.24%15.89M
-108.89%-1.52M
33.38%38.73M
21.96%-6.27M
Cash from discontinued investing activities
Investing cash flow
-82.44%2.98M
-70.48%4.47M
-39.47%9.23M
-44.10%58.56M
-8.17%11.22M
403.68%16.95M
-79.31%15.14M
-4.69%15.25M
449.41%104.75M
206.95%12.22M
Financing cash flow
Cash flow from continuing financing activities
0
-131,350.00%-2.63M
0
79.48%-2.38M
-193.81%-455K
-322.49%-1.94M
100.02%2K
109.52%4K
-114.60%-11.62M
194.36%485K
Net issuance payments of debt
--0
----
----
--0
--0
--0
----
----
---9.73M
--0
Net common stock issuance
--0
----
----
--0
171.43%35K
29.41%-12K
----
----
-100.13%-111K
-600.00%-49K
Proceeds from stock option exercised by employees
--0
--0
--0
-89.68%29K
--0
--0
--25K
-98.39%4K
-75.59%281K
312.50%33K
Net other financing activities
----
----
----
-17.08%-2.41M
-197.80%-490K
----
----
----
51.38%-2.06M
197.28%501K
Cash from discontinued financing activities
0
104.35%1K
80.65%-42K
-280K
-40K
0
-23K
-217K
0
Financing cash flow
--0
-12,395.24%-2.62M
80.28%-42K
77.07%-2.66M
-202.06%-495K
-322.49%-1.94M
99.82%-21K
-407.14%-213K
-114.60%-11.62M
194.36%485K
Net cash flow
Beginning cash position
-55.66%13.33M
-38.22%18.46M
-16.42%26.2M
29.42%31.35M
-3.23%31.12M
-40.74%30.06M
139.61%29.88M
29.42%31.35M
-4.58%24.22M
-45.17%32.15M
Current changes in cash
-171.67%-721K
-1,927.67%-5.13M
-1,018.64%-7.74M
-271.34%-7.23M
-75.15%-7.29M
105.46%1.01M
-100.66%-253K
94.06%-692K
502.87%4.22M
87.95%-4.16M
Effect of exchange rate changes
-121.15%-11K
-100.46%-2K
--0
-28.53%2.08M
-29.29%2.37M
141.94%52K
294.17%433K
-679.00%-779K
2,607.76%2.91M
3,324.49%3.36M
End cash Position
-59.52%12.6M
-55.66%13.33M
-38.22%18.46M
-16.42%26.2M
-16.42%26.2M
-3.23%31.12M
-40.74%30.06M
139.61%29.88M
29.42%31.35M
29.42%31.35M
Free cash flow
74.32%-3.7M
56.50%-7.01M
-8.13%-17.03M
28.95%-63.34M
-16.59%-17.05M
34.77%-14.42M
32.06%-16.12M
45.11%-15.75M
18.70%-89.15M
43.70%-14.62M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -152.23%-2.76M-8.20%-6.2M-31.23%-6.95M35.65%-19.85M-134.21%-14.1M124.72%5.28M75.17%-5.73M80.82%-5.3M69.06%-30.85M282.49%41.21M
Net income from continuing operations 40.72%-808K91.45%-362K51.99%-2.06M-106.14%-81.66M-575.15%-71.79M93.33%-1.36M-174.06%-4.24M89.30%-4.28M66.34%-39.62M148.32%15.11M
Operating gains losses 40.48%-2.26M-260.23%-3.43M5.43%-2.51M83.20%-12.02M86.80%-4.61M-306.75%-3.8M---953K---2.65M-255,639.29%-71.55M---34.93M
Depreciation and amortization -21.41%257K-18.21%256K2.72%264K-27.65%874K99.46%-23K-80.96%327K-83.52%313K-86.38%257K-82.47%1.21M-354.59%-4.3M
Other non cash items 48.67%168K561.29%205K-71.38%87K6.20%70.44M4.33%69.99M352.00%113K102.66%31K-21.04%304K41,553.13%66.33M2,988.49%67.08M
Change In working capital -102.39%-240K-266.91%-2.99M-386.73%-2.92M135.04%916K-457.99%-9.32M379.62%10.03M-123.54%-816K119.96%1.02M30.99%-2.61M150.43%2.6M
-Change in receivables -127.42%-1.18M-177.28%-1.5M-147.84%-819K170.23%3.63M22.66%-4.32M795.79%4.29M409.16%1.95M161.37%1.71M-250.78%-5.17M-1,103.05%-5.59M
-Change in inventory -92.16%1.02M154.44%675K-588.03%-1.61M-3,721.54%-2.48M-648.59%-14.05M1,734.18%13.04M-153.61%-1.24M80.69%-234K98.32%-65K-0.48%-1.88M
-Change in prepaid assets -94.48%104K111.07%65K-83.59%117K-73.25%656K-120.07%-1.35M367.61%1.88M-459.05%-587K120.45%713K116.42%2.45M466.11%6.75M
-Change in payables and accrued expense 100.42%39K-135.76%-2.04M49.90%-487K-133.50%-412K145.53%10.65M-211.83%-9.22M-190.41%-867K12.35%-972K81.42%1.23M589.67%4.34M
-Change in other current assets ----------0--0--------------0--0-157.36%-386K
-Change in other current liabilities -733.33%-228K-179.10%-187K42.08%-117K55.55%-473K62.15%-240K119.78%36K63.98%-67K-225.81%-202K-90.68%-1.06M-340.28%-634K
Cash from discontinued investing activities 95.12%-942K92.00%-771K4.34%-9.98M25.49%-43.27M-3.92M-19.29M-9.64M-10.43M-58.07M
Operating cash flow 73.60%-3.7M54.62%-6.98M-7.64%-16.93M29.01%-63.12M-6.81%-18.01M34.38%-14.01M33.46%-15.37M43.03%-15.73M10.80%-88.92M25.32%-16.86M
Investing cash flow
Cash flow from continuing investing activities -82.57%2.95M-70.68%4.44M-42.13%8.95M-44.92%59.77M-23.47%12.22M403.68%16.95M-79.31%15.14M-3.39%15.46M469.10%108.51M239.81%15.97M
Net PPE purchase and sale 98.78%-5K94.95%-38K-320.00%-105K3.95%-219K-56.88%968K45.70%-410K-19.37%-752K97.70%-25K97.71%-228K166.30%2.25M
Net business purchase and sale --2.96M--2.98M-57.06%7.3M-75.71%17M--0--0--0--17M--70M--20M
Net investment purchase and sale --0-90.56%1.5M215.21%1.75M10.98%42.99M279.44%11.26M321.33%17.36M-33.24%15.89M-108.89%-1.52M33.38%38.73M21.96%-6.27M
Cash from discontinued investing activities
Investing cash flow -82.44%2.98M-70.48%4.47M-39.47%9.23M-44.10%58.56M-8.17%11.22M403.68%16.95M-79.31%15.14M-4.69%15.25M449.41%104.75M206.95%12.22M
Financing cash flow
Cash flow from continuing financing activities 0-131,350.00%-2.63M079.48%-2.38M-193.81%-455K-322.49%-1.94M100.02%2K109.52%4K-114.60%-11.62M194.36%485K
Net issuance payments of debt --0----------0--0--0-----------9.73M--0
Net common stock issuance --0----------0171.43%35K29.41%-12K---------100.13%-111K-600.00%-49K
Proceeds from stock option exercised by employees --0--0--0-89.68%29K--0--0--25K-98.39%4K-75.59%281K312.50%33K
Net other financing activities -------------17.08%-2.41M-197.80%-490K------------51.38%-2.06M197.28%501K
Cash from discontinued financing activities 0104.35%1K80.65%-42K-280K-40K0-23K-217K0
Financing cash flow --0-12,395.24%-2.62M80.28%-42K77.07%-2.66M-202.06%-495K-322.49%-1.94M99.82%-21K-407.14%-213K-114.60%-11.62M194.36%485K
Net cash flow
Beginning cash position -55.66%13.33M-38.22%18.46M-16.42%26.2M29.42%31.35M-3.23%31.12M-40.74%30.06M139.61%29.88M29.42%31.35M-4.58%24.22M-45.17%32.15M
Current changes in cash -171.67%-721K-1,927.67%-5.13M-1,018.64%-7.74M-271.34%-7.23M-75.15%-7.29M105.46%1.01M-100.66%-253K94.06%-692K502.87%4.22M87.95%-4.16M
Effect of exchange rate changes -121.15%-11K-100.46%-2K--0-28.53%2.08M-29.29%2.37M141.94%52K294.17%433K-679.00%-779K2,607.76%2.91M3,324.49%3.36M
End cash Position -59.52%12.6M-55.66%13.33M-38.22%18.46M-16.42%26.2M-16.42%26.2M-3.23%31.12M-40.74%30.06M139.61%29.88M29.42%31.35M29.42%31.35M
Free cash flow 74.32%-3.7M56.50%-7.01M-8.13%-17.03M28.95%-63.34M-16.59%-17.05M34.77%-14.42M32.06%-16.12M45.11%-15.75M18.70%-89.15M43.70%-14.62M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data